The consortium Novotech which consists of Novotech Elektronik GmbH and Novotech Banksysteme GmbH was founded in 1990 and is an Upper Austrian enterprise run by a proprietor with a wide range of products and services. With currently 55 employees it embraces the following range of services: technical developments and manufacture, assembly (machine and instrument production etc.) as well as innovative products in the area of bank automation which are quite popular throughout Europe among banks and producers of self-service systems. Existing and future users of the non-invasive induction therapy with the medical technological device REHATRON™alpha profit from this experience in the areas development and production of electronic assembly and systems with modern production technologies.
You can find further information on the consortium Novotech on www.novotech.co.at.
REHATRON™alpha – a new era in cell therapy has begun.
We did not reinvent the wheel – but got the special „wheel“ REHATRON™alpha up and running. As a former producer of the non-invasive induction therapy with REHATRON™alpha we took over the production and rights of REHATRON™alpha in the summer of 2011 out of conviction. Although the non-invasive induction therapy was registered in 2005 and entered the market without far-reaching marketing measures, it has made a name among doctors and therapists as well as patients owing to its success and has a significant potential for the health care system in the future.
At this point it seems important to quote the non-medical practitioner Manfred A. Ullrich from his book „Free of pain with the non-invasive induction therapy – a new product with no competition“:
„Many non-medical practitioners, but also many representatives of orthodox medicine will have to deal with this new system because of many patient demands. In the last years a significant progress in the treatment of sports injuries, acute and chronic diseases in natural and orthodox medicine could be observed. But this therapy is a quantum leap! After many years of trials and development we now have a device at our disposal which surprises and thrills users and patients. It can repair ill cells and tissue and normalize the cellular metabolism.“
Much has been said with this statement, but we also pay attention to profitability. In times of health care reforms and a continual diminution of services by legal health insurances REHATRON™alpha is a type of therapy which guarantees an optimal integration into the practices without the necessity of additional experts. The treatments can be invoiced according to the GOÄ. For patients who had to invest a lot of money to recover, a therapy with REHATRON™alpha means a comparatively low financial expenditure without permanent (often for years) treatments. Thus REHATRON™alpha has advantages for users and patients at the same time.
It is our aim to make this extraordinary type of therapy accessible for doctors, therapists and patients. At the same time we pay attention to the highest technical quality and the use of „state-of-the-art“ technologies, and to scientific results in the area of research through clinical studies and examination in order to give the non-invasive induction therapy with REHATRON™alpha the reputation it deserves due to numerous successes in therapy.
